Citations

Showing 10 of 108094 citations.

Letter to the Editor: Missed Meals While Hospitalized for UC
Kane, Sunanda V.

Mayo Clinic

Inflammatory Bowel Diseases | February 16, 2018 | Volume: 24 | Issue: 3 | Pages: 660-660

10.1093/ibd/izx091 | PMID 29462401 Get It

Fatty acid synthase is required for profibrotic TGF‐β signaling
Kang, Jeong Han , Hernandez, Danielle M. , Yin, Xueqian , Andrianifahanana, Mahefatiana, González-Guerrico, Anatilde M., Leof, Edward B. , Jung, Mi-Yeon, Gonzalez-Guerrico, Anatilde, Lupu, Ruth , Jung, Miyeon , Wang, Youli , Limper, Andrew H.

Mayo Clinic

The FASEB Journal | February 16, 2018 | Volume: 32 | Issue: 7 | Pages: 3803-3815

10.1096/fj.201701187r | PMID 29475397 Get It

Evidence is provided that the fibroproliferative actions of TGF‐β are dependent on a metabolic adaptation that sustains pathologic growth. Specifically, profibrotic TGF‐β signaling is shown to require fatty acid synthase (FASN), an essential anabolic enzyme responsible for the de novo synthesis of fatty acids. With the use of pharmacologic and genetic approaches, we show that TGF‐β‐stimulated FASN expression is independent of Smad2/ 3 and is mediated via mammalian target of rapamycin complex 1. In the absence of FASN activity or protein, TGF‐β ‐driven fibrogenic processes are reduced with no apparent toxicity. Furthermore, as increased FASN expression was also observed to correlate with the degree of lung fibrosis in bleomycin‐treated mice, inhibition of FASN was examined in a murine‐treatment model of pulmonary fibrosis. Remarkably, inhibition of FASN not only decreased expression of profibrotic targets, but lung function was also stabilized/improved, as assessed by peripheral blood oxygenation.—Jung, M.‐Y., Kang, J.‐H., Hernandez, D. M., Yin, X., Andrianifahanana, M., Wang, Y., Gonzalez‐Guerrico, A., Limper, A. H., Lupu, R., Leof, E. B. Fatty acid synthase is required for profibrotic TGF‐β signaling. FASEB J. 32, 3803–3815 (2018). www.fasebj.org
Segmental Resection versus Total Proctocolectomy for Crohn’s Colitis: What is the Best Operation in the Setting of Medically Refractory Disease or Dysplasia?
Lightner, Amy L.

Mayo Clinic

Inflammatory Bowel Diseases | February 16, 2018 | Volume: 24 | Issue: 3 | Pages: 532-538

10.1093/ibd/izx064 | PMID 29462390 Get It

Duodenal Crohn’s Disease
Lightner, Amy L.

Mayo Clinic

Inflammatory Bowel Diseases | February 16, 2018 | Volume: 24 | Issue: 3 | Pages: 546-551

10.1093/ibd/izx083 | PMID 29462397 Get It

Simple methods to optimize the success in microsurgical submandibular gland transplantation for the treatment of patients with keratoconjunctivitis
Ciudad, Pedro , Manrique, Oscar J. , Agko, Mouchammed , Chang, Wei‐Ling , Hsu, Shao‐Yun , Trignano, Emilio , Liakos, Dimitri, Kuan, Chen‐Hsiang , Chen, Hung‐Chi, Mouchammed, Agko , Chen, Hung‐Chi

Mayo Clinic

Microsurgery | February 16, 2018 | Volume: 38 | Issue: 5 | Pages: 586-588

10.1002/micr.30308 | PMID 29451330 Get It

[18F]AV‐1451 tau‐PET and primary progressive aphasia
Josephs, Keith A. , Martin, Peter R. , Botha, Hugo , Schwarz, Christopher G. , Graff‐Radford, Jonathan , Weigand, Stephen D. , Senjem, Matthew L. , Utianski, Rene L. , Drubach, Daniel A., Petersen, Ronald C. , Jack, Clifford R. , Lowe, Val J. , Whitwell, Jennifer L. , Utianski, Rene L , Jack, Clifford R , Schwarz, Christopher G , Senjem, Matthew L , Botha, Hugo , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M. , Boeve, Bradley F. , Jones, David T. , Knopman, David S. , Whitwell, Jennifer L.

Mayo Clinic

Annals of Neurology | February 16, 2018 | Volume: 83 | Issue: 3 | Pages: 599-611

10.1002/ana.25183 | PMID 29451323 Get It

ObjectivesTo assess [18F]AV‐1451 tau‐PET (positron emission tomography) uptake patterns across the primary progressive aphasia (PPA) variants (logopenic, semantic, and agrammatic), examine regional uptake patterns of [18F]AV‐1451 independent of clinical diagnosis, and compare the diagnostic utility of [18F]AV‐1451, [18F]‐fluorodeoxygluclose (FDG)‐PET and MRI (magnetic resonance imaging) to differentiate the PPA variants.MethodsWe performed statistical parametric mapping of [18F]AV‐1451 across 40 PPA patients (logopenic‐PPA = 14, semantic‐PPA = 13, and agrammatic‐PPA = 13) compared to 80 cognitively normal, Pittsburgh compound B–negative controls, age and gender matched 2:1. Principal component analysis of regional [18F]AV‐1451 tau‐PET standard uptake value ratio was performed to understand underlying patterns of [18F]AV‐1451 uptake independent of clinical diagnosis. Penalized multinomial regression analyses were utilized to assess diagnostic utility.ResultsLogopenic‐PPA showed striking uptake throughout neocortex, particularly temporoparietal, compared to controls, semantic‐PPA, and agrammatic‐PPA. Semantic‐PPA and agrammatic‐PPA showed milder patterns of focal [18F]AV‐1451 uptake. Semantic‐PPA showed elevated uptake (left>right) in anteromedial temporal lobes, compared to controls and agrammatic‐PPA. Agrammatic‐PPA showed elevated uptake (left>right) throughout prefrontal white matter and in subcortical gray matter structures, compared to controls and semantic‐PPA. The principal component analysis of regional [18F]AV‐1451 indicated two primary dimensions, a severity dimension that distinguished logopenic‐PPA from agrammatic‐PPA and semantic‐PPA, and a frontal versus temporal contrast that distinguishes agrammatic‐PPA and semantic‐PPA cases. Diagnostic utility of [18F]AV‐1451was superior to MRI and at least equal to FDG‐PET.Interpretation[18F]AV‐1451binding characteristics differ across the PPA variants and were excellent at distinguishing between the variants. [18F]AV‐1451binding characteristics were as good or better than other brain imaging modalities utilized in clinical practice, suggesting that [18F]AV‐1451 may have clinical diagnostic utility in PPA. Ann Neurol 2018 Ann Neurol 2018;83:599–611
Magnetic Resonance Imaging and Computed Tomography of Cardiac Masses and Pseudomasses in the Atrioventricular Groove
Glockner, James F.

Mayo Clinic

Canadian Association of Radiologists Journal | February 16, 2018 | Volume: 69 | Issue: 1 | Pages: 78-91

10.1016/j.carj.2017.12.004 | PMID 29458957 Get It

The atrioventricular (AV) groove constitutes the anatomic space separating the atria and ventricles. The AV groove is often difficult to visualize at echocardiography, and suspected lesions can be further assessed with cardiac computed tomography or magnetic resonance imaging. AV groove lesions may originate from within the AV groove or extend into this space from adjacent structures. The differential diagnosis for AV groove lesions is often wide, but a precise diagnosis can sometimes be made. This pictorial essay illustrates the magnetic resonance imaging and computed tomography appearance of common and uncommon AV groove lesions, and attempts to provide a logical framework for differential diagnosis when confronted with a known or suspected lesion at cross-sectional imaging.
gBOIN: A Unified Model-Assisted Phase I Trial Design Accounting for Toxicity Grades, and Binary or Continuous End Points
Mu, Rongji , Yuan, Ying , Xu, Jin , Mandrekar, Sumithra J. , Yin, Jun

Mayo Clinic

Journal of the Royal Statistical Society Series C: Applied Statistics | February 16, 2018 | Volume: 68 | Issue: 2 | Pages: 289-308

10.1111/rssc.12263 Get It

SummaryThe landscape of oncology drug development has recently changed with the emergence of molecularly targeted agents and immunotherapies. These new therapeutic agents appear more likely to induce multiple low or moderate grade toxicities rather than dose limiting toxicities. Various model-based dose finding designs and toxicity severity scoring systems have been proposed to account for toxicity grades, but they are difficult to implement because of the use of complicated dose–toxicity models and the requirement to refit the model at each decision of dose escalation and de-escalation. We propose a generalized Bayesian optimal interval design, gBOIN, that accommodates various existing toxicity grade scoring systems under a unified framework. As a model-assisted design, gBOIN derives its optimal decision rule on the basis of the exponential family of distributions but is carried out in a simple way as the algorithm-based design: its decision of dose escalation and de-escalation involves only a simple comparison of the sample mean of the end point with two prespecified dose escalation and de-escalation boundaries. No model fitting is needed. We show that gBOIN has the desirable finite property of coherence and a large sample property of consistency. Numerical studies show that gBOIN yields good performance that is comparable with or superior to that of some existing, more complicated model-based designs. A Web application for implementing gBOIN is freely available from http://www.trialdesign.org.
Linear yellow papules following a cat scratch
Lehman, Julia S. , Nault, Ashley M., Smith, Steven A., McEvoy, Marian T., Lehman, Julia S

Mayo Clinic

International Journal of Dermatology | February 16, 2018 | Volume: 57 | Issue: 7 | Pages: 862-863

10.1111/ijd.13944 | PMID 29450887 Get It

Anesthesia and Neurodevelopment in Children
Shi, Yu , Flick, Randall P., Warner, David O.

Mayo Clinic

Anesthesiology | February 16, 2018 | Volume: 128 | Issue: 4 | Pages: 700-703

10.1097/aln.0000000000002121 | PMID 29533967 Get It